```html

Pseudogout Attacks

What is Pseudogout attacks?

Pseudogout, also called calcium pyrophosphate dihydrate (CPP‑D) crystal arthritis, is a type of inflammatory joint disease that mimics gout. A pseudogout attack occurs when calcium pyrophosphate crystals deposit in the cartilage or soft tissues of a joint and trigger an acute inflammatory response. The result is sudden, intense joint pain, swelling, warmth, and limited motion—often resembling a gout flare but usually affecting different joints.

The condition is called “pseudo‑gout” because the clinical presentation is similar to gout, yet the underlying crystals differ: gout is caused by monosodium urate crystals, whereas pseudogout involves calcium‑containing crystals. The attack can last from a few days to several weeks and may recur.

Common Causes

Unlike gout, which is strongly linked to high uric acid, pseudogout is associated with metabolic, genetic, and mechanical factors that promote crystal formation. The most frequent contributors include:

• Age‑related cartilage degeneration – the risk rises sharply after age 60.
• Joint trauma or surgery – injuries can alter cartilage matrix and promote crystal precipitation.
• Hyperparathyroidism – excess parathyroid hormone raises calcium levels, fostering CPP‑D crystal growth.
• Hypomagnesemia – low magnesium impairs the solubility of calcium pyrophosphate.
• Hemochromatosis – iron overload can deposit in joints and change cartilage chemistry.
• Low‑grade metabolic diseases such as diabetes mellitus and hypothyroidism.
• Familial chondrocalcinosis – an inherited condition that predisposes to crystal deposition.
• Chronic kidney disease – altered calcium‑phosphate balance increases crystal formation.
• Vitamin D excess or deficiency – both extremes can disturb calcium homeostasis.
• Joint overuse or repetitive stress – especially in the knees, wrists, and shoulders.

Associated Symptoms

During a pseudogout flare, patients commonly notice a cluster of symptoms that develop rapidly (often within 24 hours):

• Severe, sharp or throbbing pain localized to one joint (most often the knee, wrist, or shoulder).
• Marked swelling and palpable effusion (fluid buildup) around the joint.
• Warmth and redness of the overlying skin.
• Reduced range of motion—simple movements may be painful.
• Nighttime pain that can disrupt sleep.
• Fever or chills in about 10‑20 % of patients, especially during larger attacks.
• Occasional chondrocalcinosis visible on X‑ray (calcification of cartilage).
• Recurrent attacks that become progressively more frequent over years.

When to See a Doctor

Because pseudogout can mimic infection or other serious joint diseases, prompt medical evaluation is essential when any of the following occur:

• Sudden, severe joint pain that does not improve with rest or over‑the‑counter pain relievers.
• Rapid swelling, especially if the joint becomes visibly enlarged.
• Fever (temperature ≥ 38 °C / 100.4 °F) or chills accompanying the joint pain.
• Redness or warmth spreading beyond the joint, suggesting possible infection.
• Recent joint surgery, injection, or trauma preceding the flare.
• History of kidney disease, diabetes, or immune suppression that raises infection risk.
• Recurrent attacks that interfere with daily activities or sleep.

Early evaluation helps differentiate pseudogout from septic arthritis, gout, or rheumatologic conditions, ensuring appropriate treatment.

Diagnosis

Diagnosis rests on a combination of clinical assessment, imaging, and laboratory analysis:

1. Clinical History & Physical Exam

The physician reviews the pattern of joint involvement, recent injuries, and underlying medical conditions, then examines the affected joint for swelling, tenderness, and range of motion.

2. Joint Aspiration (Arthrocentesis)

This is the gold‑standard test. A needle draws synovial fluid from the joint, which is examined under polarized light microscopy. CPP‑D crystals appear as rhomboid or rod‑shaped structures that are positively birefringent (bright under compensating plates).

3. Laboratory Tests

• Complete blood count (CBC) – may show mild leukocytosis.
• Serum calcium, phosphate, magnesium, and parathyroid hormone – to identify metabolic triggers.
• Uric acid level – to rule out gout.
• Inflammatory markers (ESR, CRP) – typically elevated during acute attacks.

4. Imaging

• X‑ray: May reveal chondrocalcinosis (linear calcification of cartilage), especially in the knee meniscus or wrist lunate.
• Ultrasound: Detects joint effusion and crystal aggregates.
• CT or MRI: Reserved for complex cases or when infection/septic arthritis is suspected.

5. Exclusion of Other Conditions

Rheumatologists often rule out rheumatoid arthritis, osteoarthritis, and septic arthritis through the combination of the above tests.

Treatment Options

Management aims to relieve pain, reduce inflammation, prevent joint damage, and address underlying metabolic abnormalities.

Pharmacologic Therapies

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – First‑line for most patients (e.g., ibuprofen 400‑600 mg every 6 h). Use cautiously in kidney disease or gastrointestinal ulcer risk.
• Colchicine – Effective for both acute attacks and prophylaxis. Typical dosing: 1.2 mg loading dose, then 0.6 mg 1–2 h later, followed by 0.6 mg every 12 h for 2‑3 days. Adjust for renal insufficiency.
• Intra‑articular corticosteroid injection – Steroid (e.g., triamcinolone 40 mg) directly into the inflamed joint provides rapid symptom control, especially for a single large joint (knee).
• Systemic oral steroids – Prednisone 15‑30 mg daily for 5‑7 days may be used when NSAIDs/colchicine are contraindicated.
• Analgesics – Acetaminophen or low‑dose opioids for breakthrough pain under physician supervision.

Addressing Underlying Causes

• Correct hyperparathyroidism (parathyroidectomy or medication).
• Treat hypomagnesemia with oral magnesium supplements.
• Manage hemochromatosis via phlebotomy.
• Optimize blood glucose in diabetics.
• Adjust vitamin D supplementation to maintain normal levels.

Non‑pharmacologic Measures

• Rest & joint protection – Limit weight‑bearing on the affected joint for 48‑72 hours.
• Ice therapy – Apply a cold pack for 15‑20 minutes, several times daily, to decrease swelling.
• Compression – Elastic bandage can help control effusion, but avoid excessive pressure.
• Elevation – Keep the joint above heart level when seated or lying down.
• Physical therapy – Gentle range‑of‑motion exercises after the acute phase improve mobility and prevent stiffness.

Long‑Term Management

For patients with frequent attacks (≥2 per year), low‑dose colchicine (0.6 mg daily) or intermittent NSAID therapy may be prescribed as prophylaxis. Regular monitoring of renal function, liver enzymes, and blood counts is required while on chronic colchicine.

Prevention Tips

Although not all pseudogout cases are preventable, the following strategies can lower recurrence risk:

• Maintain a healthy weight to reduce joint stress.
• Stay hydrated – adequate fluid intake helps dilute calcium concentrations in synovial fluid.
• Follow a balanced diet rich in fruits, vegetables, and low‑fat dairy; limit excessive calcium supplements unless prescribed.
• Control metabolic disorders: keep calcium, phosphate, magnesium, and parathyroid hormone within normal limits.
• Avoid repetitive joint trauma; use proper technique when exercising or lifting heavy objects.
• Discuss with your physician the need for routine monitoring if you have known risk factors (e.g., hemochromatosis, hyperparathyroidism).
• Limit alcohol intake and smoking, which can exacerbate inflammation.
• Consult your doctor before starting or stopping NSAIDs, colchicine, or supplements that affect calcium balance.

Emergency Warning Signs

Key Take‑aways

Pseudogout attacks are painful, inflammatory episodes caused by calcium pyrophosphate crystal deposition. Recognizing the signs, seeking prompt evaluation, and following an evidence‑based treatment plan can relieve symptoms, protect joint health, and reduce future flare‑ups. If you have underlying metabolic disorders or recurrent attacks, working closely with a rheumatologist or primary‑care provider is essential for long‑term management.

For more detailed guidance, consult reputable resources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```